A detailed history of Jane Street Group, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 56,919 shares of NKTX stock, worth $141,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56,919
Previous 108,377 47.48%
Holding current value
$141,159
Previous $640,000 59.84%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.52 - $8.0 $232,590 - $411,664
-51,458 Reduced 47.48%
56,919 $257,000
Q2 2024

Aug 14, 2024

SELL
$5.27 - $10.82 $71,935 - $147,693
-13,650 Reduced 11.19%
108,377 $640,000
Q1 2024

May 15, 2024

SELL
$5.59 - $15.71 $135,300 - $380,244
-24,204 Reduced 16.55%
122,027 $1.32 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $191,562 - $965,124
146,231 New
146,231 $965,000
Q2 2023

Aug 14, 2023

BUY
$2.19 - $5.17 $34,111 - $80,527
15,576 New
15,576 $34,000
Q4 2022

Feb 14, 2023

BUY
$5.14 - $14.35 $170,092 - $474,870
33,092 New
33,092 $198,000
Q2 2022

Aug 16, 2022

BUY
$7.77 - $19.44 $81,950 - $205,033
10,547 New
10,547 $130,000
Q2 2021

Aug 16, 2021

SELL
$23.94 - $36.68 $220,152 - $337,309
-9,196 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$31.33 - $59.61 $288,110 - $548,173
9,196 New
9,196 $303,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $121M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.